Low adiponectin expression has been linked to a variety of human metabolic disorders and malignancies, Ahn et al. synthesized 2-formyl-komarovicine (Figure 46) and evaluated adiponectin secretion by performing the phenotypic assay on human bone marrow–mesenchymal stem cells (hBM-MSCs). Here, ADIPOQ is linked to metabolic disease.